Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
18.38
+0.22 (1.21%)
Apr 8, 2026, 4:00 PM EDT - Market closed
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $3.03 billion as of April 9, 2026. Its market cap has increased by 121.97% in one year.
Market Cap
3.03B
Enterprise Value
2.09B
1-Year Change
121.97%
Ranking
Category
Stock Price
$18.38
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $3.03B, an increase of 283.51%. That is a compound annual growth rate of 27.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 3.00B | -6.95% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.19B |
| Denali Therapeutics | 3.08B |
| Catalyst Pharmaceuticals | 3.05B |
| Oruka Therapeutics | 3.00B |
| Tarsus Pharmaceuticals | 2.93B |
| Travere Therapeutics | 2.92B |
| Arcutis Biotherapeutics | 2.89B |
| Vera Therapeutics | 2.85B |